BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24688485)

  • 21. Transcriptional repression of plasma cell differentiation is orchestrated by aberrant over-expression of the ETS factor SPIB in Waldenström macroglobulinaemia.
    Zhou Y; Liu X; Xu L; Hunter ZR; Cao Y; Yang G; Carrasco R; Treon SP
    Br J Haematol; 2014 Sep; 166(5):677-89. PubMed ID: 24801987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germinal center-independent, IgM-mediated autoimmunity in sanroque mice lacking Obf1.
    Chevrier S; Kratina T; Emslie D; Karnowski A; Corcoran LM
    Immunol Cell Biol; 2014 Jan; 92(1):12-9. PubMed ID: 24217807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
    Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
    J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity.
    Annweiler A; Müller-Immerglück M; Wirth T
    Mol Cell Biol; 1992 Jul; 12(7):3107-16. PubMed ID: 1620119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional differences between the Oct2 transactivation domains determine the transactivation potential of individual Oct2 isoforms.
    Annweiler A; Zwilling S; Wirth T
    Nucleic Acids Res; 1994 Oct; 22(20):4250-8. PubMed ID: 7937153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1.
    Karnowski A; Chevrier S; Belz GT; Mount A; Emslie D; D'Costa K; Tarlinton DM; Kallies A; Corcoran LM
    J Exp Med; 2012 Oct; 209(11):2049-64. PubMed ID: 23045607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the aldehyde dehydrogenase 2-like gene is controlled by BOB.1/OBF.1 in B lymphocytes.
    Brunner C; Laumen H; Nielsen PJ; Kraut N; Wirth T
    J Biol Chem; 2003 Nov; 278(46):45231-9. PubMed ID: 12947107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular principles of Oct2-mediated gene activation in B cells.
    Wirth T; Pfisterer P; Annweiler A; Zwilling S; König H
    Immunobiology; 1995 Jul; 193(2-4):161-70. PubMed ID: 8530140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NF-κB-dependent signals control BOB.1/OBF.1 and Oct2 transcriptional activity in B cells.
    Kilzheimer M; Quandt J; Langhans J; Weihrich P; Wirth T; Brunner C
    Eur J Immunol; 2015 Dec; 45(12):3441-53. PubMed ID: 26361887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple Oct2 isoforms are generated by alternative splicing.
    Wirth T; Priess A; Annweiler A; Zwilling S; Oeler B
    Nucleic Acids Res; 1991 Jan; 19(1):43-51. PubMed ID: 2011512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The B cell transcriptional coactivator BOB1/OBF1 gene fuses to the LAZ3/BCL6 gene by t(3;11)(q27;q23.1) chromosomal translocation in a B cell leukemia line (Karpas 231).
    Galiègue Zouitina S; Quief S; Hildebrand MP; Denis C; Lecocq G; Collyn-d'Hooghe M; Bastard C; Yuille M; Dyer MJ; Kerckaert JP
    Leukemia; 1996 Apr; 10(4):579-87. PubMed ID: 8618432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B lymphocytes are impaired in mice lacking the transcriptional co-activator Bob1/OCA-B/OBF1.
    Nielsen PJ; Georgiev O; Lorenz B; Schaffner W
    Eur J Immunol; 1996 Dec; 26(12):3214-8. PubMed ID: 8977324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription.
    Stein H; Marafioti T; Foss HD; Laumen H; Hummel M; Anagnostopoulos I; Wirth T; Demel G; Falini B
    Blood; 2001 Jan; 97(2):496-501. PubMed ID: 11154228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific interaction of TAFII105 with OCA-B is involved in activation of octamer-dependent transcription.
    Wolstein O; Silkov A; Revach M; Dikstein R
    J Biol Chem; 2000 Jun; 275(22):16459-65. PubMed ID: 10828057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The OBF1 protein and its DNA-binding site are important for the function of an autonomously replicating sequence in Saccharomyces cerevisiae.
    Walker SS; Francesconi SC; Tye BK; Eisenberg S
    Mol Cell Biol; 1989 Jul; 9(7):2914-21. PubMed ID: 2674674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The multifunctional protein OBF1 is phosphorylated at serine and threonine residues in Saccharomyces cerevisiae.
    Francesconi SC; Eisenberg S
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4089-93. PubMed ID: 2034654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Btk expression is controlled by Oct and BOB.1/OBF.1.
    Brunner C; Wirth T
    Nucleic Acids Res; 2006; 34(6):1807-15. PubMed ID: 16582106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells.
    Theil J; Laumen H; Marafioti T; Hummel M; Lenz G; Wirth T; Stein H
    Blood; 2001 May; 97(10):3191-6. PubMed ID: 11342448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fusion of the LAZ3/BCL6 and BOB1/OBF1 genes by t(3; 11) (q27; q23) chromosomal translocation.
    Galiègue-Zouitina S; Quief S; Hildebrand MP; Denis C; Lecocq G; Collyn-d'Hooghe M; Bastard C; Yuille M; Dyer MJ; Kerckaert JP
    C R Acad Sci III; 1995 Nov; 318(11):1125-31. PubMed ID: 8574789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of target genes of the lymphoid-specific transcription factor Oct2.
    Pfisterer P; Hess J; Wirth T
    Immunobiology; 1997 Dec; 198(1-3):217-26. PubMed ID: 9442393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.